UNASSIGNED: Retrospective chart review from January 2007 to July 2018 at a tertiary pediatric care center. Consecutive patients with PARD who underwent VFIA, who had a preoperative voice evaluation and a follow-up evaluation within 3 months after VFIA (fat, carboxymethylcellulose gel, hyaluronic acid).
UNASSIGNED: Thirty-four patients (20 female) underwent VFIA. The mean age at the time of the injection was 13.6 years (SD 6.1). Twenty patients (58.8%) had a history of prematurity and a mean of 1.8 open airway surgeries. After injection, 29/34 patients (85.3%) noted a subjective voice improvement. The baseline Consensus Auditory-Perceptual Evaluation of Voice (CAPE-V) overall severity score decreased by a mean of 5.7 (SD = 19.6) points, P = .12. Total pediatric Voice Handicap Index (pVHI) improved by 6.0 (SD = 19.5) points, from 57.4 (SD = 20.0) to 51.4 (SD = 17.2), P = .09. Functional pVHI subscore demonstrated a significant improvement, with a decrease of 3.4 (SD = 7.3) points, P = .02. All procedures were performed as an overnight observation and no complication occurred.
UNASSIGNED: Patients with PARD represent a complex subset of patients. VFIA is a straightforward intervention that may improve voice perception. Many patients reported subjective improvement despite minimal objective measurement. Further work is warranted to elucidate the role of injection in management of PARD.
■2007年1月至2018年7月在三级儿科护理中心进行的回顾性图表回顾。连续接受VFIA的PARD患者,VFIA后3个月内进行了术前语音评估和随访评估(脂肪,羧甲基纤维素凝胶,透明质酸)。
■34名患者(20名女性)接受了VFIA。注射时的平均年龄为13.6岁(SD6.1)。20例患者(58.8%)有早产史,平均进行1.8次开放气道手术。注射后,29/34例患者(85.3%)注意到主观声音改善。基线一致听觉-感知语音评估(CAPE-V)总体严重程度评分平均下降5.7分(SD=19.6),P=.12。总儿科语音障碍指数(pVHI)提高了6.0(SD=19.5)分,从57.4(SD=20.0)到51.4(SD=17.2),P=.09。功能pVHI子评分显示出显着改善,下降3.4(SD=7.3)点,P=.02。所有程序均为过夜观察,无并发症发生。
■PARD患者代表患者的复杂子集。VFIA是一种直接的干预措施,可以改善语音感知。尽管客观测量最小,但许多患者报告主观改善。需要进一步的工作来阐明注射在PARD管理中的作用。